Core Insights - a2 Milk Company reported a 13.5% increase in annual revenue to NZD 1.902 billion for the fiscal year ending June 30, 2025, with a net profit after tax (NPAT) growth of 21.1% to NZD 202.9 million [1] - The company experienced significant growth in the Chinese and other Asian markets, with a revenue increase of 13.9% to NZD 1.302 billion, and a 22.5% growth in the U.S. market, while the Australia-New Zealand region remained stable [1] - The infant formula segment grew by 9.9%, with the a2 Platinum infant formula series generating NZD 632.5 million, a 3.3% increase year-on-year [1] Regional Performance - In the Chinese and other Asian regions, the revenue from family nutrition products surged by 33.1% to NZD 110.3 million [2] - The sales of English standard products in China and other Asian regions reached NZD 559.1 million, reflecting a 24.9% year-on-year growth [1][2] - The overall cross-border infant formula market grew by 11.9% year-on-year, driven by increasing market demand and a trend towards premiumization, with the cross-border segment's market share rising from 14% in FY22 to 19% [1] Strategic Developments - The company acquired an integrated nutrition product manufacturing facility in Pokeno, New Zealand, from Yashili New Zealand Dairy Co., Limited, for approximately NZD 282 million [2] - Following the acquisition, a2 Milk Company plans to invest around NZD 100 million in the new Pokeno facility to enhance production capacity and create over 100 new jobs [2] - The company aims to secure product registrations for two new national standard infant formula products, with potential for a third registration in the future [3]